Guggenheim Capital’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Sell |
44,936
-2,188
| -5% | -$94.5K | 0.02% | 663 |
|
|
2025
Q1 | $1.63M | Buy |
47,124
+2,463
| +6% | +$85.1K | 0.02% | 697 |
|
|
2024
Q4 | $1.23M | Sell |
44,661
-6,340
| -12% | -$174K | 0.01% | 822 |
|
|
2024
Q3 | $1.3M | Buy |
51,001
+1,425
| +3% | +$36.3K | 0.01% | 980 |
|
|
2024
Q2 | $1.26M | Sell |
49,576
-760
| -2% | -$19.3K | 0.01% | 1000 |
|
|
2024
Q1 | $1.56M | Buy |
50,336
+9,508
| +23% | +$294K | 0.01% | 991 |
|
|
2023
Q4 | $1.65M | Buy |
+40,828
| New | +$1.65M | 0.01% | 923 |
|
|
2022
Q1 | – | Sell |
-59,838
| Closed | -$999K | – | 2122 |
|
|
2021
Q4 | $999K | Buy |
59,838
+8,739
| +17% | +$146K | 0.01% | 1371 |
|
|
2021
Q3 | $2.4M | Buy |
51,099
+5,350
| +12% | +$251K | 0.01% | 964 |
|
|
2021
Q2 | $2.79M | Buy |
+45,749
| New | +$2.79M | 0.02% | 919 |
|